New study tracks kidney health in diabetes patients on finerenone
NCT ID NCT07554469
First seen Apr 29, 2026 · Last updated May 15, 2026 · Updated 4 times
Summary
This study will follow 500 adults in Spain with chronic kidney disease and type 2 diabetes who are taking finerenone. Researchers want to see if a tool called the Klinrisk score, which estimates kidney disease progression, improves after 2 years of treatment. The study will collect data from routine check-ups and monitor any side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Many locations
Many Locations, Spain
Conditions
Explore the condition pages connected to this study.